FITC anti-human CD150 (SLAM)
- Manufacturer
- BioLegend
- Catalog Number
- 306306
- Host
- Mouse
- Reactivity
- Baboon, Cynomolgus Monkey, Human, Rhesus
- Applications
- Flow Cytometry
To help shape future technologies — and be in with a chance of winning a $500/£400/450 € Amazon Gift Card — cast your vote for the product which made the most difference to the lab in 2018
Find out what caused a real buzz at the 70th Annual Scientific Meeting and Clinical Lab Expo
Significant impact on mice survival and skin graft rejection vs. control in relevant GvHD and skin transplant models
Waters demonstrates the power and potential of mass spectrometry by showcasing new technologies
Rigaku NEX LS scanner performs multi-element composition, coat weight and coating thickness analyses for web and coil applications
CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF
Ncardia develops, produces and commercializes highly predictive human cellular assay systems for safety and efficacy testing. The product portfolio encompasses a broad panel of hiPSC derived cryopreserved cardiomyocytes and neurons. In addition, the company delivers the CardioPlateTM product line of quality controlled ready to use assay plates. Using its cell products, Ncardia develops and provides its customers with a broad portfolio of cardiovascular services from safety pharmacology and disease modeling to cardiovascular drug efficacy screening. Ncardia is based in Belgium, The Netherlands, Germany, and the USA. The company is privately held and was established in September 2017 following the merger of Pluriomics and Axiogenesis, two well-known pioneers in the field of stem cell derived cells for safety and toxicology assessment.
Atrandi Biosciences, founded in 2016, is a pioneering life sciences tool company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology. This next-generation technology isolates tens of thousands of single cells within discrete, permeable compartments, allowing bulk reactions to proceed as usual while preserving single-cell resolution. SPCs have already unlocked previously inaccessible applications, such as high-throughput microbial and eukaryotic genomics, and are poised to enable true single-cell multiomics. Headquartered in Vilnius, Lithuania, Atrandi’s name, meaning “you discover” in Lithuanian, embodies the company’s mission to empower scientists to uncover the unknown and make groundbreaking discoveries. Company Facts: 200+ satisfied customers 150+ install base 20+ collaborations worldwide 65 employees and growing ISO 9001 & ISO 14001 certified
A best-in-class DNA transfection reagent for your research.